全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

淫羊藿主要化学成分及其药理作用研究进展
Research Progress on the Main Chemical Components and Pharmacological Effects of Epimedium

DOI: 10.12677/hjbm.2024.144067, PP. 616-623

Keywords: 淫羊藿,主要成分,药理作用,分子机制
Epimedium
, Main Components, Pharmacological Effects, Molecular Mechanism

Full-Text   Cite this paper   Add to My Lib

Abstract:

淫羊藿作为传统中药中的一种重要药材,其根、根茎、茎和叶均具有显著的药用价值。它被广泛应用于治疗祛风除湿和补肾壮阳等症状。现代医学研究显示,淫羊藿含有多种活性成分,如总黄酮和淫羊藿苷,这些成分具有抗炎、抗氧化、抗肿瘤、抗骨质疏松和抗细胞凋亡等药理作用。本篇文章在现有成果的基础上,系统总结了淫羊藿的活性成分及其在治疗骨质疏松、乳腺癌、阿尔茨海默病、心力衰竭和哮喘等多种疾病的药理作用及其潜在机制,旨在通过深入分析淫羊藿的活性成分和作用机制,扩展其临床应用范围,并探索其与其他治疗方法的联合用药效果。期望通过这些研究,进一步阐明淫羊藿的作用机制,促进传统中药与现代医疗的融合,为患者提供更为全面和有效的治疗方案。
As an important medicinal material in traditional Chinese medicine, Epimedium has significant medicinal value in its roots, rhizome, stem and leaves. It is widely used to treat symptoms such as expelling wind and removing dampness, tonifying kidney and strengthening yang. Modern medical research shows that Epimedium contains multiple active ingredients, such as total flavonoids and icariin, which have pharmacological effects such as anti-inflammatory, anti-oxidant, anti-tumor, anti-osteoporosis and anti-apoptosis. Based on the existing results, this article systematically summarizes the active ingredients of Epimedium and its pharmacological effects and potential mechanisms in the treatment of various diseases such as osteoporosis, breast cancer, Alzheimer’s disease, heart failure and asthma. It aims to expand its clinical application scope by conducting an in-depth analysis of Epimedium’s active ingredients and mechanisms of action, and explore its combination effect with other treatment methods. It is expected that these studies will further clarify the mechanism of action of Epimedium, promote the integration of traditional Chinese medicine and modern medical care, and provide patients with more comprehensive and effective treatment plans.

References

[1]  李建国, 谢兴文, 李鼎鹏, 等. 中药淫羊藿治疗骨质疏松症的研究进展[J]. 中国骨质疏松杂志, 2018, 24(3): 389-393.
[2]  李梨, 周岐新, 石京山. 淫羊藿苷药理作用研究进展[J]. 中国药房, 2005, 16(12): 952-954.
[3]  李莉, 王嘉瑞, 王晶, 等. 淫羊藿的主要化学成分, 药理作用研究进展及质量标志物的预测分析[J]. 中华中医药学刊, 2023, 41(11): 143-151.
[4]  梁利香, 付雪丽, 王海燕, 等. 基于不同炮制方法的淫羊藿黄酮类成分含量研究[J]. 饲料工业, 2024, 45(9): 107-114.
[5]  Shi, S., Wang, F., Huang, Y., Chen, B., Pei, C., Huang, D., et al. (2022) Epimedium for Osteoporosis Based on Western and Eastern Medicine: An Updated Systematic Review and Meta-Analysis. Frontiers in Pharmacology, 13, Article ID: 782096.
https://doi.org/10.3389/fphar.2022.782096
[6]  付亮, 袁璟亚, 丁春邦, 等. 四川不同产地淫羊藿总黄酮及淫羊藿苷含量的分析测定[J]. 现代中药研究与实践, 2015, 29(5): 27-31.
[7]  Quan, Q.-M. (2011) Comparative Analysis of Morphological Characteristics and Effective Composition Content of Wild and Cultivated Epimedium pubescens and Epimedium wushanense (Berberidaceae). Journal of Medicinal Plants Research, 5, 6523-6527.
https://doi.org/10.5897/jmpr11.602
[8]  Wang, C., Tian, S., Tang, Q., Zhou, Z., Peng, X., Cai, X., et al. (2023) Systematic Quality Evaluation of Epimedium wushanense T. S. Ying Based on Two Quality Control Standards: Total Flavonoid Glycosides and Epimedin C. Chemistry & Biodiversity, 20, e202200579.
https://doi.org/10.1002/cbdv.202200579
[9]  王悦云, 王雪飞, 刘娇, 等. 不同产地巫山淫羊藿指纹图谱的主成分、因子和聚类分析[J]. 中国实验方剂学杂志, 2019, 25(7): 165-172.
[10]  李永志, 韩礼军, 李智斌, 等. 秦岭箭叶淫羊藿对骨质疏松大鼠骨代谢及胫骨骨微结构的影响[J]. 疑难病杂志, 2024, 23(8): 993-998+1001.
[11]  李伟娟, 谢保平, 石丽颖, 等. 从ERα/RANK通路探讨淫羊藿苷抑制破骨细胞分化作用[J]. 中国实验方剂学杂志, 2017, 23(7): 121-126.
[12]  胡阳亮, 黎欢, 姬贵梅, 等. 箭叶淫羊藿中具有HDAC抑制活性的化学成分研究[J]. 天然产物研究与开发, 2021, 33(10): 1681.
[13]  戴燚, 范彦博, 刘静, 等. 山奈酚通过Wnt/β-catenin信号通路调节骨细胞合成代谢进而改善骨质疏松的作用机制[J]. 中国老年学杂志, 2023, 43(12): 3001-3005.
[14]  Pan, C., Zhang, C., Lin, Z., Liang, Z., Cui, Y., Shang, Z., et al. (2024) Disulfidptosis-Related Protein RPN1 May Be a Novel Anti-Osteoporosis Target of Kaempferol. Combinatorial Chemistry & High Throughput Screening, 27, 1611-1628.
https://doi.org/10.2174/0113862073273655231213070619
[15]  Zheng, R., Zhang, S., Zeng, H., Wang, S., Sun, K., Chen, R., et al. (2022) Cancer Incidence and Mortality in China, 2016. Journal of the National Cancer Center, 2, 1-9.
https://doi.org/10.1016/j.jncc.2022.02.002
[16]  Cantor, S.B. and Calvo, J.A. (2017) Fork Protection and Therapy Resistance in Hereditary Breast Cancer. Cold Spring Harbor Symposia on Quantitative Biology, 82, 339-348.
https://doi.org/10.1101/sqb.2017.82.034413
[17]  Gohr, K., Hamacher, A., Engelke, L.H. and Kassack, M.U. (2017) Inhibition of PI3K/Akt/mTOR Overcomes Cisplatin Resistance in the Triple Negative Breast Cancer Cell Line HCC38. BMC Cancer, 17, Article No. 711.
https://doi.org/10.1186/s12885-017-3695-5
[18]  华辞怡, 史有阳, 谢颖, 等. 淫羊藿有效成分治疗乳腺癌作用机制的研究进展[J]. 中草药, 2022, 53(20): 6593-6600.
[19]  钱丹萍. 淫羊藿苷调控MELK抑制乳腺癌细胞的作用及相关信号通路研究[D]: [博士学位论文]. 南京: 南京中医药大学, 2023.
[20]  刘卫国, 何利芳, 顾玲, 等. 淫羊藿素对乳腺癌细胞化疗敏感的影响机制研究[J]. 广西医科大学学报, 2022(4): 39.
[21]  Haraldstad, K., Wahl, A., Andenæs, R., Andersen, J.R., Andersen, M.H., Beisland, E., et al. (2019) A Systematic Review of Quality of Life Research in Medicine and Health Sciences. Quality of Life Research, 28, 2641-2650.
https://doi.org/10.1007/s11136-019-02214-9
[22]  王焕珍, 柴艺汇, 陈云志, 等. 淫羊藿化学成分与药理作用研究进展[J]. 亚太传统医药, 2016, 12(7): 63-65.
[23]  刘颖. 淫羊藿及其主要成分朝藿定A对骨质疏松影响及机制的研究[D]: [博士学位论文]. 呼和浩特: 内蒙古农业大学, 2018.
[24]  司玉芳, 严少普, 王文博. 淫羊藿苷改善中枢神经系统疾病的研究进展[J]. 现代药物与临床, 2023, 38(4): 988-994.
[25]  郑桃林, 王哲, 刘超, 等. 淫羊藿苷对阿尔茨海默病细胞模型糖原合成酶激酶-3β表达的影响及机制[J]. 中国老年学杂志, 2016, 36(4): 800-803.
[26]  甄瑾, 李润今, 王梅玲. 淫羊藿苷对阿尔茨海默病模型大鼠记忆能力及其海马内GFAP、TNF-α、IL-6表达的影响[J]. 中西医结合心脑血管病杂志, 2013, 11(2): 192-194.
[27]  栾剑, 宋雨桐, 周婷婷, 等. 中西医药物治疗阿尔茨海默症的研究进展[J]. 生物化工, 2023, 9(6): 188-191.
[28]  贾亮亮, 胡月琴. 基于网络药理学及分子对接技术探讨淫羊藿治疗心力衰竭的作用机制[J]. 巴楚医学, 2024, 7(2): 69-75.
[29]  李楠, 王保和, 张晨, 等. 淫羊藿苷对心血管疾病作用机制研究进展[J]. 天津中医药, 2023, 40(1): 126-130.
[30]  王颖婉, 李叶丽, 王俊逸, 等. PPARα、PPARγ的上调参与淫羊藿苷对自发性高血压大鼠心室重构的调节[J]. 中国药理学通报, 2015, 31(8): 1117-1120.
[31]  袁晶, 陈智昌, 焦福智, 等. 淫羊藿苷对心血管疾病保护作用研究进展[J]. 环球中医药, 2021, 14(5): 981-986.
[32]  方东菲, 张建永. 淫羊藿及其活性成分对心血管疾病的改善作用机制研究进展[J]. 中国药房, 2020, 31(9): 1139-1143.
[33]  贺娟梅, 李小荣, 李复红. 支气管哮喘流行病学观察以及危险因素分析[J]. 山西医科大学学报, 2015, 46(12): 1224-1227.
[34]  阳艳丽, 潘玉琴, 何帮顺, 等. 哮喘患儿外周血调节性T细胞和Th1/Th2的变化及其与哮喘病情的关系[J]. 中国当代儿科杂志, 2011, 13(6): 482-486.
[35]  李竹英, 陈璐, 王丽洁, 等. 淫羊藿苷治疗支气管哮喘作用机制的网络药理学研究[J]. 中国中医急症, 2021, 30(8): 1317-1320, 1344.
[36]  唐秀凤, 李晓曦, 年宏蕾, 等. 淫羊藿女贞子影响激素干预哮喘大鼠与炎性因子相关的pJAKs/pSTATs的研究[J]. 环球中医药, 2018, 11(2): 172-177.
[37]  王瀚, 马紫童, 唐秀凤, 等. 基于网络药理学探寻淫羊藿治疗哮喘的关键靶标及作用机制[J]. 世界中医药, 2021, 16(5): 742-750.
[38]  何银童. 雾化吸入淫羊藿素对哮喘小鼠气道炎症及气道重塑的影响[D]: [硕士学位论文]. 桂林: 桂林医学院, 2022.
[39]  伍利芝. 淫羊藿素对支气管哮喘气道重塑的作用研究[D]: [硕士学位论文]. 桂林: 桂林医学院, 2019.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133